EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tacrolimus Induced Hypertension and Vascular Remodeling Includes Mechanisms of Cellular Senescence—The Protective Effect of Valsartan

Lingyan Fei iD, Xiaohua Wang, Lingyi Kong, Tianjiao Cui, Pratik H Khedkar iD, Yunxiu Xiang, Dongliang Zhao, Junxuan Fang, Yulin Liang, Yangyang Zhang, Nan Xu, Xingyu Qiu und 12 weitere

Acta Physiologica · 2026

DOI: 10.1111/apha.70189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Physiologica, 2026. Verfasst von Lingyan Fei und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Center of Kidney and Urology, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China. Hauptthemen laut MEDLINE: Valsartan, Cellular Senescence, Vascular Remodeling, Hypertension. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Postdoctoral Science Foundation of China, Research Start-up Fund of Post-doctoral of Sahsysu.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Calcineurin inhibitors (CNI) such as tacrolimus (Tac) are the first‐line treatment to prevent transplant rejection. However, CNI have adverse effects on blood vessels and renal function, which may be linked to cellular senescence. Valsartan, a common angiotensin II type 1 receptor (AT 1 R) blocker, exhibits anti‐senescence properties. We tested the hypothesis that tacrolimus causes hypertension and microvascular remodeling that involves induction of senescence, and that valsartan is protective.

Methods

Microperfusion and wire myography were employed to assess the contractile and dilatory functions of renal afferent arterioles (Af‐Art) and mesenteric arteries, respectively. The expression of components of the renin‐angiotensin system (RAS) and senescence‐associated biomarkers was investigated using qPCR and immunohistochemistry.

Results

Long‐term administration of Tac activated the RAS. Tac‐induced microvascular remodeling in mesenteric arteries and Af‐Art was mitigated by treatment with valsartan. Mice treated with Tac exhibited increased vasoconstriction in response to angiotensin II and reduced dilation to acetylcholine. Both effects were abolished by valsartan. Additionally, senescence‐associated biomarkers were upregulated in mesenteric and renal resistance arteries from Tac‐treated mice. Co‐administration of Tac with valsartan or ABT‐263, a senolytic agent, rescued Tac‐induced microvascular injury and reduced hypertension (conscious mice, noninvasive tail‐cuff system). Treatment with the antihypertensive drug amlodipine normalized blood pressure and downregulated senescence‐associated beta‐galactosidase in mesenteric arteries.

Conclusion

These findings suggest that cellular senescence contributes to Tac‐induced microvascular injury and hypertension and demonstrate the effectiveness of senolytic treatment for protection. Valsartan could reduce senescence indirectly by lowering blood pressure; a direct anti‐senescence effect might also play a role in this context.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ValsartanCellular SenescenceVascular RemodelingHypertensionTacrolimusAnimalsMiceMaleAngiotensin II Type 1 Receptor BlockersAntihypertensive AgentsMice, Inbred C57BLRenin-Angiotensin SystemImmunosuppressive Agents

Stichwörter der Autor:innen

cellular senescencemicrovascular dysfunctionsenolytic drugtacrolimusvalsartan

Substanzen

ValsartanTacrolimusAngiotensin II Type 1 Receptor BlockersAntihypertensive AgentsImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Nephrology, Center of Kidney and Urology, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China.
  • Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Institute of Translational Physiology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
  • Department of Pathology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Henan University, Kaifeng, China.
  • Department of Physiology, School of Basic Medical Sciences, Zhejiang University School of Medicine, Hangzhou, China.

ORCID-Profile: Lingyan Fei, Pratik H Khedkar, Gensheng Zhang, Kongyang Ma, Liwei Lu, En Yin Lai, Pontus B Persson

Förderung

  • National Natural Science Foundation of China
  • Postdoctoral Science Foundation of China
  • Research Start-up Fund of Post-doctoral of Sahsysu
  • Shenzhen Science and Technology Innovation Program
  • Shenzhen Medical Research Fund
  • Science, Technology and Innovation Commission of Shenzhen Municipality

Zitieren

APA

Fei, L., Wang, X., Kong, L., Cui, T., Khedkar, P. H., Xiang, Y., Zhao, D., Fang, J., Liang, Y., Zhang, Y., Xu, N., Qiu, X., Zhao, L., Zhang, G., Lei, Y., Tang, C., Ma, K., Lu, L., Wei, J., …, & Jiang, S. (2026). Tacrolimus Induced Hypertension and Vascular Remodeling Includes Mechanisms of Cellular Senescence—The Protective Effect of Valsartan. Acta Physiologica. https://doi.org/10.1111/apha.70189

Vancouver

Fei L, Wang X, Kong L, Cui T, Khedkar PH, Xiang Y, et al. Tacrolimus Induced Hypertension and Vascular Remodeling Includes Mechanisms of Cellular Senescence—The Protective Effect of Valsartan. Acta Physiologica. 2026. doi:10.1111/apha.70189

BibTeX
@article{Fei2026,
  author = {Fei, Lingyan and Wang, Xiaohua and Kong, Lingyi and Cui, Tianjiao and Khedkar, Pratik H and Xiang, Yunxiu and Zhao, Dongliang and Fang, Junxuan and Liang, Yulin and Zhang, Yangyang and Xu, Nan and Qiu, Xingyu and Zhao, Liang and Zhang, Gensheng and Lei, Yan and Tang, Chun and Ma, Kongyang and Lu, Liwei and Wei, Jin and Lai, En Yin and Persson, Pontus B and Patzak, Andreas and Zheng, Zhihua and Jiang, Shan},
  title = {Tacrolimus Induced Hypertension and Vascular Remodeling Includes Mechanisms of Cellular Senescence—The Protective Effect of Valsartan},
  journal = {Acta Physiologica},
  year = {2026},
  doi = {10.1111/apha.70189}
}
Kostenlos starten →